Seeking Alpha

Array BioPharma (ARRY +2.4%) trades up after announcing positive results from Phase 1 and 2...

Array BioPharma (ARRY +2.4%) trades up after announcing positive results from Phase 1 and 2 testing of its kinesin spindle protein inhibitor, ARRY-520, yesterday at the annual meeting of the American Society of Hematology in San Diego, California.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)